Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Apply
Retifanlimab, Bevacizumab, Hypofractionated Radiotherapy
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step